CD73 regulates zoledronate-induced lymphocyte infiltration in triple-negative breast cancer tumors and lung metastases

INTRODUCTION: Bisphosphonates (BPs) are bone-protecting osteoclast inhibitors, typically used in the treatment of osteoporosis and skeletal complications of malignancies. When given in the adjuvant setting, these drugs may also prevent relapses and prolong overall survival in early breast cancer (EB...

Descripción completa

Detalles Bibliográficos
Autores principales: Petruk, Nataliia, Siddiqui, Arafat, Tadayon, Sina, Määttä, Jorma, Mattila, Pieta K., Jukkola, Arja, Sandholm, Jouko, Selander, Katri S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390692/
https://www.ncbi.nlm.nih.gov/pubmed/37533856
http://dx.doi.org/10.3389/fimmu.2023.1179022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390692/
https://www.ncbi.nlm.nih.gov/pubmed/37533856
http://dx.doi.org/10.3389/fimmu.2023.1179022

Ejemplares similares